{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:24Z","timestamp":1786982244577,"version":"build-2736575974"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Patients with cirrhosis frequently require procedures and are at risk of bleeding related to interventions. Procedural bleeding adversely impacts patients with cirrhosis and is associated with mortality. Assessment of bleeding risk in these patients is complex due to changes in hemostasis, portal hypertension, elevated thrombosis risk, and comorbid infection and renal disease. This clinical review will discuss current data regarding risk assessment, prevention, and management of procedural bleeding in patients with cirrhosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Risk of procedural bleeding in patients with cirrhosis involves patient-related and procedure-related factors. Conventional hemostasis parameters such as prothrombin time and platelet count are not predictive of bleeding in cirrhosis and may lead providers to overestimate bleeding risk. Hepatic decompensation, kidney injury, metabolic syndrome, alcohol use, and infections are all associated with increased bleeding risk. Procedure type, urgency, and operator experience also influence procedural bleeding risk. Historically pre-procedural transfusion support has been used in attempt to mitigate procedural bleeding risk. However, mounting data argues against this approach. Patient optimization, procedure conditions, and procedure technique can minimize bleeding risk. Viscoelastic testing may be useful to reduce the use of prophylactic transfusion and reassure proceduralists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Historically, the risk of procedural bleeding has been overestimated in patients with cirrhosis due to abnormal conventional coagulation testing including prolonged prothrombin time and thrombocytopenia. Prophylactic transfusion has not been consistently demonstrated to reduce bleeding risk and carries some risks. Performing only necessary procedures under optimal conditions with safe technique and preparation for rescue transfusion can minimize procedural-associated bleeding and its consequences.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12072-025-10834-2","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:11:47Z","timestamp":1752138707000},"page":"1035-1050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Advances in the prevention and management of procedural bleeding in patients with cirrhosis"],"prefix":"10.1007","volume":"19","author":[{"given":"Jessica P. E.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Q.","family":"Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas M.","family":"Intagliata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"issue":"3","key":"10834_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1053\/j.gastro.2023.05.046","volume":"165","author":"NM Intagliata","year":"2023","unstructured":"Intagliata NM, Rahimi RS, Higuera-de-la-Tijera F, et al. Procedural-related bleeding in hospitalized patients with liver disease (PROC-BLeeD): an international, prospective, multicenter observational study. Gastroenterology 2023;165(3):717\u2013732. https:\/\/doi.org\/10.1053\/j.gastro.2023.05.046","journal-title":"Gastroenterology"},{"issue":"5","key":"10834_CR2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2023.01.010","volume":"78","author":"A Zanetto","year":"2023","unstructured":"Zanetto A, Northup P, Roberts L, Senzolo M. Haemostasis in cirrhosis: understanding destabilising factors during acute decompensation. J Hepatol 2023;78(5):1037\u20131047. https:\/\/doi.org\/10.1016\/j.jhep.2023.01.010","journal-title":"J Hepatol"},{"issue":"8","key":"10834_CR3","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/s2468-1253(24)00078-5","volume":"9","author":"S Piano","year":"2024","unstructured":"Piano S, Bunchorntavakul C, Marciano S, Rajender RK. Infections in cirrhosis. Lancet Gastroenterol Hepatol 2024;9(8):745\u2013757. https:\/\/doi.org\/10.1016\/s2468-1253(24)00078-5","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10834_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.cgh.2019.04.057","volume":"18","author":"M Premkumar","year":"2020","unstructured":"Premkumar M, Bihari C, Saxena P, et al. Heparin-like effect associated with risk of bleeding, sepsis, and death in patients with severe alcohol-associated hepatitis. Clin Gastroenterol Hepatol 2020;18(2):486-495.e3. https:\/\/doi.org\/10.1016\/j.cgh.2019.04.057","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10834_CR5","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.jhep.2023.06.001","volume":"79","author":"M Senzolo","year":"2023","unstructured":"Senzolo M, Garcia-Pagan JC. A major research gap: the use of anticoagulants in cirrhosis. J Hepatol 2023;79(6):1566\u20131570. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.001","journal-title":"J Hepatol"},{"issue":"6","key":"10834_CR6","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","volume":"116","author":"T Lisman","year":"2010","unstructured":"Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010;116(6):878\u2013885. https:\/\/doi.org\/10.1182\/blood-2010-02-261891","journal-title":"Blood"},{"issue":"1","key":"10834_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/hep.31646","volume":"73","author":"PG Northup","year":"2021","unstructured":"Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73(1):366\u2013413. https:\/\/doi.org\/10.1002\/hep.31646","journal-title":"Hepatology"},{"issue":"2","key":"10834_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/nejmra1011170","volume":"365","author":"A Tripodi","year":"2011","unstructured":"Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011;365(2):147\u2013156. https:\/\/doi.org\/10.1056\/nejmra1011170","journal-title":"N Engl J Med"},{"issue":"6","key":"10834_CR9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1160\/th08-01-0006","volume":"99","author":"M Uemura","year":"2008","unstructured":"Uemura M, Fujimura Y, Matsumoto M, et al. Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis. Thromb Haemost 2008;99(6):1019\u201329. https:\/\/doi.org\/10.1160\/th08-01-0006","journal-title":"Thromb Haemost"},{"issue":"3","key":"10834_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/hep.20569","volume":"41","author":"A Tripodi","year":"2005","unstructured":"Tripodi A, Salerno F, Chantarangkul V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005;41(3):553\u2013558. https:\/\/doi.org\/10.1002\/hep.20569","journal-title":"Hepatology"},{"issue":"5","key":"10834_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/bf01313579","volume":"26","author":"K Ewe","year":"1981","unstructured":"Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981;26(5):388\u2013393. https:\/\/doi.org\/10.1007\/bf01313579","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10834_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s001340050884","volume":"25","author":"NC Fisher","year":"1999","unstructured":"Fisher NC, Mutimer DJ. Central venous cannulation in patients with liver disease and coagulopathy - a prospective audit. Intensive Care Med 1999;25(5):481\u2013485. https:\/\/doi.org\/10.1007\/s001340050884","journal-title":"Intensive Care Med"},{"issue":"2","key":"10834_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/hep.20317","volume":"40","author":"CM Grabau","year":"2004","unstructured":"Grabau CM, Crago SF, Hoff LK, et al. Performance standards for therapeutic abdominal paracentesis. Hepatology 2004;40(2):484\u2013488. https:\/\/doi.org\/10.1002\/hep.20317","journal-title":"Hepatology"},{"issue":"2","key":"10834_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jhep.2007.05.001","volume":"47","author":"G Kalambokis","year":"2007","unstructured":"Kalambokis G, Manousou P, Vibhakorn S, et al. Transjugular liver biopsy \u2013 Indications, adequacy, quality of specimens, and complications \u2013 a systematic review. J Hepatol 2007;47(2):284\u2013294. https:\/\/doi.org\/10.1016\/j.jhep.2007.05.001","journal-title":"J Hepatol"},{"issue":"8","key":"10834_CR15","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/apt.16078","volume":"52","author":"AJ Kovalic","year":"2020","unstructured":"Kovalic AJ, Majeed CN, Samji NS, Thuluvath PJ, Satapathy SK. Systematic review with meta-analysis: abnormalities in the international normalised ratio do not correlate with periprocedural bleeding events among patients with cirrhosis. Aliment Pharmacol Ther 2020;52(8):1298\u20131310. https:\/\/doi.org\/10.1111\/apt.16078","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10834_CR16","doi-asserted-by":"publisher","first-page":"e00288","DOI":"10.14309\/ctg.0000000000000288","volume":"11","author":"S Kundumadam","year":"2020","unstructured":"Kundumadam S, Phatharacharukul P, Reinhart K, et al. Bleeding after elective interventional endoscopic procedures in a large cohort of patients with cirrhosis. Clin Transl Gastroenterol 2020;11(12):e00288. https:\/\/doi.org\/10.14309\/ctg.0000000000000288","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"10834_CR17","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/0016-5085(90)91167-5","volume":"99","author":"DB McGill","year":"1990","unstructured":"McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99(5):1396\u20131400. https:\/\/doi.org\/10.1016\/0016-5085(90)91167-5","journal-title":"Gastroenterology"},{"issue":"8","key":"10834_CR18","doi-asserted-by":"publisher","first-page":"692.e9","DOI":"10.1016\/j.crad.2017.03.001","volume":"72","author":"JG Park","year":"2017","unstructured":"Park JG, Park SY, Tak WY, et al. Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience over 10 years. Clin Radiol 2017;72(8):692.e9-692.e15. https:\/\/doi.org\/10.1016\/j.crad.2017.03.001","journal-title":"Clin Radiol"},{"issue":"3","key":"10834_CR19","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.joms.2011.10.033","volume":"70","author":"JPV Perdig\u00e3o","year":"2012","unstructured":"Perdig\u00e3o JPV, de Almeida PC, Rocha TDS, et al. Postoperative bleeding after dental extraction in liver pretransplant patients. J Oral Maxillofac Surg 2012;70(3):e177\u2013e184. https:\/\/doi.org\/10.1016\/j.joms.2011.10.033","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"10834_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cgh.2010.03.025","volume":"8","author":"LB Seeff","year":"2010","unstructured":"Seeff LB, Everson GT, Morgan TR, et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 2010;8(10):877\u2013883. https:\/\/doi.org\/10.1016\/j.cgh.2010.03.025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10834_CR21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.5009\/gnl19131","volume":"14","author":"H Soh","year":"2020","unstructured":"Soh H, Chun J, Hong SW, et al. Child-Pugh B or C cirrhosis increases the risk for bleeding following colonoscopic polypectomy. Gut Liver 2020;14(6):755\u2013764. https:\/\/doi.org\/10.5009\/gnl19131","journal-title":"Gut Liver"},{"issue":"1","key":"10834_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0002-9343(01)00744-6","volume":"111","author":"X Xiol","year":"2001","unstructured":"Xiol X, Castellote J, Cortes-Beut R, Delgado M, Guardiola J, Ses\u00e9 E. Usefulness and complications of thoracentesis in cirrhotic patients. Am J Med 2001;111(1):67\u201369. https:\/\/doi.org\/10.1016\/s0002-9343(01)00744-6","journal-title":"Am J Med"},{"issue":"9","key":"10834_CR23","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cgh.2009.04.019","volume":"7","author":"EC Vieira da Rocha","year":"2009","unstructured":"Vieira da Rocha EC, D\u2019Amico EA, Caldwell SH, et al. A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation. Clin Gastroenterol Hepatol 2009;7(9):988\u2013993. https:\/\/doi.org\/10.1016\/j.cgh.2009.04.019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10834_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/meg.0000000000001948","volume":"34","author":"N Janko","year":"2022","unstructured":"Janko N, Majeed A, Commins I, Kemp W, Roberts SK. Procedural bleeding risk, rather than conventional coagulation tests, predicts procedure related bleeding in cirrhosis. Eur J Gastroenterol Hepatol 2022;34(2):192\u2013199. https:\/\/doi.org\/10.1097\/meg.0000000000001948","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10834_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jhep.2019.09.008","volume":"72","author":"AB Rassi","year":"2020","unstructured":"Rassi AB, d\u2019Amico EA, Tripodi A, et al. Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: effect on conventional coagulation tests and thrombomodulin-modified thrombin generation. J Hepatol 2020;72(1):85\u201394. https:\/\/doi.org\/10.1016\/j.jhep.2019.09.008","journal-title":"J Hepatol"},{"issue":"4","key":"10834_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/s0168-8278(02)00208-8","volume":"37","author":"P Montalto","year":"2002","unstructured":"Montalto P, Vlachogiannakos J, Cox DJ, Pastacaldi S, Patch D, Burroughs AK. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 2002;37(4):463\u2013470. https:\/\/doi.org\/10.1016\/s0168-8278(02)00208-8","journal-title":"J Hepatol"},{"issue":"17","key":"10834_CR27","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1182\/blood-2018-10-833988","volume":"133","author":"R Goel","year":"2019","unstructured":"Goel R, Tobian AAR, Shaz BH. Noninfectious transfusion-associated adverse events and their mitigation strategies. Blood 2019;133(17):1831\u20131839. https:\/\/doi.org\/10.1182\/blood-2018-10-833988","journal-title":"Blood"},{"issue":"01","key":"10834_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1160\/th16-06-0450","volume":"117","author":"P Ambrosino","year":"2017","unstructured":"Ambrosino P, Tarantino L, Di Minno G, et al. The risk of venous thromboembolism in patients with cirrhosis. Thromb Haemost 2017;117(01):139\u2013148. https:\/\/doi.org\/10.1160\/th16-06-0450","journal-title":"Thromb Haemost"},{"issue":"10241","key":"10834_CR29","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/s0140-6736(20)30848-5","volume":"395","author":"I Roberts","year":"2020","unstructured":"Roberts I, Shakur-Still H, Afolabi A, Akere A, Arribas M, Brenner A, et al. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet 2020;395(10241):1927\u20131936. https:\/\/doi.org\/10.1016\/s0140-6736(20)30848-5","journal-title":"Lancet"},{"issue":"5","key":"10834_CR30","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","volume":"76","author":"E Villa","year":"2022","unstructured":"Villa E, Bianchini M, Blasi A, Denys A, Giannini EG, de Gottardi A, et al. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol 2022;76(5):1151\u20131184. https:\/\/doi.org\/10.1016\/j.jhep.2021.09.003","journal-title":"J Hepatol"},{"issue":"5","key":"10834_CR31","doi-asserted-by":"publisher","first-page":"1615.e1","DOI":"10.1053\/j.gastro.2021.08.015","volume":"161","author":"RS O'Shea","year":"2021","unstructured":"O\u2019Shea RS, Davitkov P, Ko CW, et al. AGA clinical practice guideline on the management of coagulation disorders in patients with cirrhosis. Gastroenterology 2021;161(5):1615.e1-1627.e1. https:\/\/doi.org\/10.1053\/j.gastro.2021.08.015","journal-title":"Gastroenterology"},{"issue":"2","key":"10834_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jhep.2022.09.005","volume":"78","author":"A Zanetto","year":"2023","unstructured":"Zanetto A, Pelizzaro F, Campello E, et al. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis. J Hepatol 2023;78(2):301\u2013311. https:\/\/doi.org\/10.1016\/j.jhep.2022.09.005","journal-title":"J Hepatol"},{"key":"10834_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jcrc.2017.07.053","volume":"43","author":"C Fisher","year":"2018","unstructured":"Fisher C, Patel VC, Stoy SH, et al. Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure. J Crit Care 2018;43:54\u201360. https:\/\/doi.org\/10.1016\/j.jcrc.2017.07.053","journal-title":"J Crit Care"},{"issue":"6","key":"10834_CR34","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/hep.30103","volume":"68","author":"A Blasi","year":"2018","unstructured":"Blasi A, Calvo A, Prado V, et al. Coagulation failure in patients with acute-on-chronic liver failure and decompensated cirrhosis: beyond the international normalized ratio. Hepatology 2018;68(6):2325\u20132337. https:\/\/doi.org\/10.1002\/hep.30103","journal-title":"Hepatology"},{"issue":"49","key":"10834_CR35","doi-asserted-by":"publisher","first-page":"e2225","DOI":"10.1097\/MD.0000000000002225","volume":"94","author":"S Lin","year":"2015","unstructured":"Lin S, Wang M, Zhu Y, et al. Hemorrhagic complications following abdominal paracentesis in acute on chronic liver failure: a propensity score analysis. Medicine (Baltimore) 2015;94(49):e2225\u2013e2225. https:\/\/doi.org\/10.1097\/MD.0000000000002225","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10834_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/a-1515-9529","volume":"122","author":"J Thaler","year":"2022","unstructured":"Thaler J, Lisman T, Quehenberger P, et al. Intraperitoneal activation of coagulation and fibrinolysis in patients with cirrhosis and ascites. Thromb Haemost 2022;122(3):353\u2013362. https:\/\/doi.org\/10.1055\/a-1515-9529","journal-title":"Thromb Haemost"},{"issue":"7","key":"10834_CR37","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1046\/j.1538-7836.2003.00298.x","volume":"1","author":"KG Mann","year":"2003","unstructured":"Mann KG, Brummel K, Butenas S. What is all that thrombin for? J Thromb Haemost 2003;1(7):1504\u20131514. https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00298.x","journal-title":"J Thromb Haemost"},{"key":"10834_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejim.2016.11.007","volume":"38","author":"G Napolitano","year":"2017","unstructured":"Napolitano G, Iacobellis A, Merla A, et al. Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia. Eur J Intern Med 2017;38:79\u201382. https:\/\/doi.org\/10.1016\/j.ejim.2016.11.007","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10834_CR39","doi-asserted-by":"publisher","first-page":"e13508","DOI":"10.1111\/eci.13508","volume":"51","author":"D Alvaro","year":"2021","unstructured":"Alvaro D, Caporaso N, Giannini EG, et al. Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia. Eur J Clin Invest 2021;51(6):e13508. https:\/\/doi.org\/10.1111\/eci.13508","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10834_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5604\/01.3001.0010.8635","volume":"17","author":"JPE Davis","year":"2018","unstructured":"Davis JPE, Northup PG, Caldwell SH, Intagliata NM. Viscoelastic testing in liver disease. Ann Hepatol 2018;17(2):205\u2013213. https:\/\/doi.org\/10.5604\/01.3001.0010.8635","journal-title":"Ann Hepatol"},{"issue":"6","key":"10834_CR41","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s12072-020-10093-3","volume":"14","author":"P Raeven","year":"2020","unstructured":"Raeven P, Baron-Stefaniak J, Simbrunner B, et al. Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension. Hepatol Int 2020;14(6):1083\u20131092. https:\/\/doi.org\/10.1007\/s12072-020-10093-3","journal-title":"Hepatol Int"},{"issue":"2","key":"10834_CR42","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/hep.28148","volume":"63","author":"L De Pietri","year":"2016","unstructured":"De Pietri L, Bianchini M, Montalti R, et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial. Hepatology 2016;63(2):566\u2013573. https:\/\/doi.org\/10.1002\/hep.28148","journal-title":"Hepatology"},{"issue":"1","key":"10834_CR43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/hep.30794","volume":"71","author":"M Kumar","year":"2019","unstructured":"Kumar M, Ahmad J, Maiwall R, et al. Thromboelastography-guided blood component use in patients with cirrhosis with nonvariceal bleeding: a randomized controlled trial. Hepatology 2019;71(1):235\u2013246. https:\/\/doi.org\/10.1002\/hep.30794","journal-title":"Hepatology"},{"issue":"11","key":"10834_CR44","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1007\/s10620-021-07376-6","volume":"67","author":"A Shenoy","year":"2022","unstructured":"Shenoy A, Louissaint J, Shannon C, Tapper EB, Lok AS. Viscoelastic testing prior to non-surgical procedures reduces blood product use without increasing bleeding risk in cirrhosis. Dig Dis Sci 2022;67(11):5290\u20135299. https:\/\/doi.org\/10.1007\/s10620-021-07376-6","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10834_CR45","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1016\/j.transproceed.2010.05.144","volume":"42","author":"SC Wang","year":"2010","unstructured":"Wang SC, Shieh JF, Chang KY, et al. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transpl Proc 2010;42(7):2590\u20132593. https:\/\/doi.org\/10.1016\/j.transproceed.2010.05.144","journal-title":"Transpl Proc"},{"issue":"1","key":"10834_CR46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/ijmr.IJMR_749_14","volume":"145","author":"CK Pandey","year":"2017","unstructured":"Pandey CK, Saluja V, Gaurav K, Tandon M, Pandey VK, Bhadoria AS. K time & maximum amplitude of thromboelastogram predict post-central venous cannulation bleeding in patients with cirrhosis: a pilot study. Indian J Med Res 2017;145(1):84\u201389. https:\/\/doi.org\/10.4103\/ijmr.IJMR_749_14","journal-title":"Indian J Med Res"},{"issue":"2","key":"10834_CR47","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/hep4.1641","volume":"5","author":"A Zanetto","year":"2020","unstructured":"Zanetto A, Rinder HM, Senzolo M, Simioni P, Garcia-Tsao G. Reduced clot stability by thromboelastography as a potential indicator of procedure-related bleeding in decompensated cirrhosis. Hepatol Commun 2020;5(2):272\u2013282. https:\/\/doi.org\/10.1002\/hep4.1641","journal-title":"Hepatology communications"},{"issue":"7","key":"10834_CR48","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/liv.13728","volume":"38","author":"M Bianchini","year":"2018","unstructured":"Bianchini M, Cavani G, Bonaccorso A, et al. Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients. Liver Int 2018;38(7):1253\u20131262. https:\/\/doi.org\/10.1111\/liv.13728","journal-title":"Liver Int"},{"issue":"5","key":"10834_CR49","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/meg.0000000000001061","volume":"30","author":"M Guillaume","year":"2018","unstructured":"Guillaume M, Christol C, Plessier A, et al. Bleeding risk of variceal band ligation in extrahepatic portal vein obstruction is not increased by oral anticoagulation. Eur J Gastroenterol Hepatol 2018;30(5):563\u2013568. https:\/\/doi.org\/10.1097\/meg.0000000000001061","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10834_CR50","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/meg.0000000000001522","volume":"32","author":"S Ponthus","year":"2020","unstructured":"Ponthus S, Spahr L, Casini A, et al. Safety of variceal band ligation in patients with cirrhosis and portal vein thrombosis treated with anticoagulant therapy: a retrospective study. Eur J Gastroenterol Hepatol 2020;32(3):395\u2013400. https:\/\/doi.org\/10.1097\/meg.0000000000001522","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10834_CR51","first-page":"3","volume-title":"Introduction: Baveno I to Baveno VII \u2026 and Beyond. Portal Hypertension VII","author":"R de Franchis","year":"2022","unstructured":"de Franchis R. Introduction: Baveno I to Baveno VII \u2026 and Beyond. Portal Hypertension VII. Springer International Publishing; 2022. p. 3\u20137"},{"issue":"Suppl 3","key":"10834_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00508-023-02229-w","volume":"135","author":"M Mandorfer","year":"2023","unstructured":"Mandorfer M, Aigner E, Cejna M, et al. Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV). Wien Klin Wochenschr 2023;135(Suppl 3):493\u2013523. https:\/\/doi.org\/10.1007\/s00508-023-02229-w","journal-title":"Wien Klin Wochenschr"},{"issue":"3","key":"10834_CR53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/ejh.13363","volume":"104","author":"JPE Davis","year":"2020","unstructured":"Davis JPE, O\u2019Leary KE, Intagliata NM. Overuse of venous thromboembolism prophylaxis among hospitalized patients with liver disease. Eur J Haematol 2020;104(3):223\u2013229. https:\/\/doi.org\/10.1111\/ejh.13363","journal-title":"Eur J Haematol"},{"issue":"1","key":"10834_CR54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/phar.2485","volume":"41","author":"AL Bixby","year":"2020","unstructured":"Bixby AL, Lichvar AB, Salerno D, Park JM. Use of direct-acting oral anticoagulants in solid organ transplantation: a systematic review. Pharmacotherapy 2020;41(1):28\u201343. https:\/\/doi.org\/10.1002\/phar.2485","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10834_CR55","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1097\/TP.0000000000004014","volume":"106","author":"E Montalv\u00e1","year":"2022","unstructured":"Montalv\u00e1 E, Rodr\u00edguez-Per\u00e1lvarez M, Blasi A, et al. Consensus statement on hemostatic management, anticoagulation, and antiplatelet therapy in liver transplantation. Transplantation 2022;106(6):1123\u20131131. https:\/\/doi.org\/10.1097\/TP.0000000000004014","journal-title":"Transplantation"},{"issue":"5","key":"10834_CR56","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.surg.2023.02.001","volume":"173","author":"HJ Madsen","year":"2023","unstructured":"Madsen HJ, Gillette RA, Colborn KL, et al. The association between obesity and postoperative outcomes in a broad surgical population: a 7-year American College of Surgeons National Surgical Quality Improvement analysis. Surgery 2023;173(5):1213\u20131219. https:\/\/doi.org\/10.1016\/j.surg.2023.02.001","journal-title":"Surgery"},{"issue":"8","key":"10834_CR57","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/lt.24134","volume":"21","author":"JG Stine","year":"2015","unstructured":"Stine JG, Shah NL, Argo CK, Pelletier SJ, Caldwell SH, Northup PG. Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis. Liver Transplant 2015;21(8):1016\u20131021. https:\/\/doi.org\/10.1002\/lt.24134","journal-title":"Liver Transplant"},{"issue":"3","key":"10834_CR58","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1055\/s-0029-1222606","volume":"35","author":"G Targher","year":"2009","unstructured":"Targher G, Chonchol M, Miele L, Zoppini G, Pichiri I, Muggeo M. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. Semin Thromb Hemost 2009;35(3):277\u201387. https:\/\/doi.org\/10.1055\/s-0029-1222606","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10834_CR59","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0272-6386(85)80112-8","volume":"5","author":"SJ Jubelirer","year":"1985","unstructured":"Jubelirer SJ. Hemostatic abnormalities in renal disease. Am J Kidney Dis 1985;5(5):219\u201325. https:\/\/doi.org\/10.1016\/s0272-6386(85)80112-8","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10834_CR60","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0049-3848(87)90091-0","volume":"45","author":"DS Holloway","year":"1987","unstructured":"Holloway DS, Vagher JP, Caprini JA, Simon NM, Mockros LF. Thrombelastography of blood from subjects with chronic renal failure. Thromb Res 1987;45(6):817\u2013825. https:\/\/doi.org\/10.1016\/0049-3848(87)90091-0","journal-title":"Thromb Res"},{"issue":"4","key":"10834_CR61","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1046\/j.1523-1755.2003.00211.x","volume":"64","author":"BH Prinsen","year":"2003","unstructured":"Prinsen BH, Rabelink TJ, Beutler JJ, et al. Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure. Kidney Int 2003;64(4):1495\u2013504. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00211.x","journal-title":"Kidney Int"},{"issue":"10","key":"10834_CR62","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.dld.2019.03.011","volume":"51","author":"NM Intagliata","year":"2019","unstructured":"Intagliata NM, Davis JPE, Lafond J, et al. Acute kidney injury is associated with low factor XIII in decompensated cirrhosis. Dig Liver Dis 2019;51(10):1409\u20131415. https:\/\/doi.org\/10.1016\/j.dld.2019.03.011","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10834_CR63","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/hep.31443","volume":"72","author":"A Zanetto","year":"2020","unstructured":"Zanetto A, Rinder HM, Campello E, et al. Acute kidney injury in decompensated cirrhosis is associated with both hypo-coagulable and hyper-coagulable features. Hepatology (Baltimore, Md) 2020;72(4):1327\u20131340. https:\/\/doi.org\/10.1002\/hep.31443","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"8","key":"10834_CR64","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/liv.13712","volume":"38","author":"A Hung","year":"2018","unstructured":"Hung A, Garcia-Tsao G. Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis. Liver Int 2018;38(8):1437\u20131441. https:\/\/doi.org\/10.1111\/liv.13712","journal-title":"Liver Int"},{"issue":"4","key":"10834_CR65","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/hep.510290437","volume":"29","author":"GV Papatheodoridis","year":"1999","unstructured":"Papatheodoridis GV, Patch D, Webster GJ, Brooker J, Barnes E, Burroughs AK. Infection and hemostasis in decompensated cirrhosis: a prospective study using thrombelastography. Hepatology 1999;29(4):1085\u20131090. https:\/\/doi.org\/10.1002\/hep.510290437","journal-title":"Hepatology"},{"issue":"5","key":"10834_CR66","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2036.2011.04746.x","volume":"34","author":"NC Chavez-Tapia","year":"2011","unstructured":"Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, et al. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review. Aliment Pharmacol Ther 2011;34(5):509\u2013518. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04746.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10834_CR67","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","volume":"8","author":"S Schulman","year":"2010","unstructured":"Schulman S, Anger\u00e5s U, Bergqvist D, Eriksson B, Lassen MR, Fisher W. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 2010;8(1):202\u2013204. https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03678.x","journal-title":"J Thromb Haemost"},{"key":"10834_CR68","doi-asserted-by":"publisher","first-page":"S258","DOI":"10.1016\/s0168-8278(23)00826-7","volume":"78","author":"A Riescher-Tuczkiewicz","year":"2023","unstructured":"Riescher-Tuczkiewicz A, Caldwell SH, Villa E, Rautou P-E. Classification of bleeding risk from invasive procedures in patients with cirrhosis: an expert consensus. J Hepatol 2023;78:S258\u2013S260. https:\/\/doi.org\/10.1016\/s0168-8278(23)00826-7","journal-title":"J Hepatol"},{"key":"10834_CR69","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-230X-12-173","volume":"12","author":"M Mueller","year":"2012","unstructured":"Mueller M, Kratzer W, Oeztuerk S, et al. Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years. BMC Gastroenterol 2012;12:173\u2013173. https:\/\/doi.org\/10.1186\/1471-230X-12-173","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10834_CR70","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1097\/sla.0000000000003674","volume":"274","author":"KM Johnson","year":"2019","unstructured":"Johnson KM, Newman KL, Green PK, et al. Incidence and risk factors of postoperative mortality and morbidity after elective versus emergent abdominal surgery in a national sample of 8193 patients with cirrhosis. Ann Surg 2019;274(4):e345\u2013e354. https:\/\/doi.org\/10.1097\/sla.0000000000003674","journal-title":"Ann Surg"},{"key":"10834_CR71","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-230X-10-5","volume":"10","author":"F Petrasch","year":"2010","unstructured":"Petrasch F, Grothaus J, M\u00f6ssner J, Schiefke I, Hoffmeister A. Differences in bleeding behavior after endoscopic band ligation: a retrospective analysis. BMC Gastroenterol 2010;10:5. https:\/\/doi.org\/10.1186\/1471-230X-10-5","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10834_CR72","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1378\/chest.12-2374","volume":"144","author":"RM Hibbert","year":"2013","unstructured":"Hibbert RM, Atwell TD, Lekah A, et al. Safety of ultrasound-guided thoracentesis in patients with abnormal preprocedural coagulation parameters. Chest 2013;144(2):456\u2013463. https:\/\/doi.org\/10.1378\/chest.12-2374","journal-title":"Chest"},{"issue":"8","key":"10834_CR73","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.jvir.2016.05.010","volume":"27","author":"AK Pillai","year":"2016","unstructured":"Pillai AK, Andring B, Faulconer N, et al. Utility of intravascular US-guided portal vein access during transjugular intrahepatic portosystemic shunt creation: retrospective comparison with conventional technique in 109 patients. J Vasc Interv Radiol 2016;27(8):1154\u20131159. https:\/\/doi.org\/10.1016\/j.jvir.2016.05.010","journal-title":"J Vasc Interv Radiol"},{"key":"10834_CR74","doi-asserted-by":"publisher","DOI":"10.1097\/hc9.0000000000000577","author":"H Tang","year":"2024","unstructured":"Tang H, Kaplan DE, Abu-Gazala S, Mahmud N. Recent TIPS increases postoperative mortality: a national cohort study. Hepatol Commun. 2024. https:\/\/doi.org\/10.1097\/hc9.0000000000000577","journal-title":"Hepatol Commun"},{"issue":"2","key":"10834_CR75","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/hep.28628","volume":"64","author":"A Drolz","year":"2016","unstructured":"Drolz A, Horvatits T, Roedl K, et al. Coagulation parameters and major bleeding in critically ill patients with cirrhosis. Hepatology 2016;64(2):556\u2013568. https:\/\/doi.org\/10.1002\/hep.28628","journal-title":"Hepatology"},{"issue":"10","key":"10834_CR76","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1055\/a-1355-3716","volume":"121","author":"IM Budnick","year":"2021","unstructured":"Budnick IM, Davis JPE, Sundararaghavan A, et al. Transfusion with cryoprecipitate for very low fibrinogen levels does not affect bleeding or survival in critically Ill cirrhosis patients. Thromb Haemost 2021;121(10):1317\u20131325. https:\/\/doi.org\/10.1055\/a-1355-3716","journal-title":"Thromb Haemost"},{"issue":"5","key":"10834_CR77","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/mpg.0b013e3182a0e0d8","volume":"57","author":"SS Short","year":"2013","unstructured":"Short SS, Papillon S, Hunter CJ, et al. Percutaneous liver biopsy. J Pediatr Gastroenterol Nutr 2013;57(5):644\u2013648. https:\/\/doi.org\/10.1097\/mpg.0b013e3182a0e0d8","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10834_CR78","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/nejmoa1211801","volume":"368","author":"C Villanueva","year":"2013","unstructured":"Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013;368(1):11\u201321. https:\/\/doi.org\/10.1056\/nejmoa1211801","journal-title":"N Engl J Med"},{"issue":"6","key":"10834_CR79","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cgh.2018.11.047","volume":"17","author":"H Hidaka","year":"2019","unstructured":"Hidaka H, Kurosaki M, Tanaka H, et al. Lusutrombopag reduces need for platelet transfusion in patients with thrombocytopenia undergoing invasive procedures. Clin Gastroenterol Hepatol 2019;17(6):1192\u20131200. https:\/\/doi.org\/10.1016\/j.cgh.2018.11.047","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10834_CR80","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/hep.30561","volume":"70","author":"M Peck-Radosavljevic","year":"2019","unstructured":"Peck-Radosavljevic M, Simon K, Iacobellis A, et al. Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS 2). Hepatology (Baltimore, Md) 2019;70(4):1336\u20131348. https:\/\/doi.org\/10.1002\/hep.30561","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"2","key":"10834_CR81","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00535-018-1499-2","volume":"54","author":"R Tateishi","year":"2019","unstructured":"Tateishi R, Seike M, Kudo M, et al. A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation. J Gastroenterol 2019;54(2):171\u2013181. https:\/\/doi.org\/10.1007\/s00535-018-1499-2","journal-title":"J Gastroenterol"},{"issue":"3","key":"10834_CR82","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1053\/j.gastro.2018.05.025","volume":"155","author":"N Terrault","year":"2018","unstructured":"Terrault N, Chen Y-C, Izumi N, et al. Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia. Gastroenterology 2018;155(3):705\u2013718. https:\/\/doi.org\/10.1053\/j.gastro.2018.05.025","journal-title":"Gastroenterology"},{"issue":"1","key":"10834_CR83","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/09537104.2020.1859102","volume":"33","author":"I Lindquist","year":"2022","unstructured":"Lindquist I, Olson SR, Li A, et al. The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis. Platelets 2022;33(1):66\u201372. https:\/\/doi.org\/10.1080\/09537104.2020.1859102","journal-title":"Platelets"},{"issue":"11","key":"10834_CR84","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1111\/liv.13882","volume":"38","author":"T Lisman","year":"2018","unstructured":"Lisman T, Kleiss S, Patel VC, et al. In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis. Liver Int 2018;38(11):1988\u20131996. https:\/\/doi.org\/10.1111\/liv.13882","journal-title":"Liver Int"},{"issue":"12","key":"10834_CR85","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1111\/trf.14328","volume":"57","author":"AC Colavecchia","year":"2017","unstructured":"Colavecchia AC, Cohen DA, Harris JE, et al. Impact of intraoperative factor concentrates on blood product transfusions during orthotopic liver transplantation. Transfusion 2017;57(12):3026\u20133034. https:\/\/doi.org\/10.1111\/trf.14328","journal-title":"Transfusion"},{"key":"10834_CR86","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13435","author":"P Srivastava","year":"2018","unstructured":"Srivastava P, Agarwal A, Jha A, et al. Utility of prothrombin complex concentrate as first-line treatment modality of coagulopathy in patients undergoing liver transplantation: a propensity score-matched study. Clin Transplant. 2018. https:\/\/doi.org\/10.1111\/ctr.13435","journal-title":"Clin Transplant"},{"issue":"4","key":"10834_CR87","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jhep.2018.11.019","volume":"70","author":"M Tischendorf","year":"2019","unstructured":"Tischendorf M, Fuchs A, Zeuzem S, Lange CM. Use of prothrombin complex concentrates in patients with decompensated liver cirrhosis is associated with thromboembolic events. J Hepatol 2019;70(4):800\u2013801. https:\/\/doi.org\/10.1016\/j.jhep.2018.11.019","journal-title":"J Hepatol"},{"issue":"5","key":"10834_CR88","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/hep.22216","volume":"47","author":"J Bosch","year":"2008","unstructured":"Bosch J, Thabut D, Albillos A, et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology 2008;47(5):1604\u20131614. https:\/\/doi.org\/10.1002\/hep.22216","journal-title":"Hepatology"},{"issue":"1","key":"10834_CR89","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1600-6143.2006.01591.x","volume":"7","author":"IQ Molenaar","year":"2007","unstructured":"Molenaar IQ, Warnaar N, Groen H, TenVergert EM, Slooff MJH, Porte RJ. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant 2007;7(1):185\u2013194. https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01591.x","journal-title":"Am J Transplant"},{"issue":"3","key":"10834_CR90","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1213\/ane.0000000000006804","volume":"139","author":"S Dehne","year":"2024","unstructured":"Dehne S, Riede C, Feisst M, et al. Tranexamic acid administration during liver transplantation is not associated with lower blood loss or with reduced utilization of red blood cell transfusion. Anesth Analg 2024;139(3):598\u2013608. https:\/\/doi.org\/10.1213\/ane.0000000000006804","journal-title":"Anesth Analg"},{"issue":"7","key":"10834_CR91","doi-asserted-by":"publisher","first-page":"CD012293","DOI":"10.1002\/14651858.CD012293.pub2","volume":"7","author":"ET Engelen","year":"2018","unstructured":"Engelen ET, Schutgens RE, Mauser-Bunschoten EP, van Es RJ, van Galen KP. Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions. Cochrane Database Syst Rev 2018;7(7):CD012293. https:\/\/doi.org\/10.1002\/14651858.CD012293.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10834_CR92","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/jth.13140","volume":"13","author":"S Kaatz","year":"2015","unstructured":"Kaatz S, Ahmad D, Spyropoulos AC, Schulman S. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 2015;13(11):2119\u20132126. https:\/\/doi.org\/10.1111\/jth.13140","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10834_CR93","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/lt.20559","volume":"12","author":"L Massicotte","year":"2005","unstructured":"Massicotte L, Lenis S, Thibeault L, Sassine M-P, Seal RF, Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 2005;12(1):117\u2013123. https:\/\/doi.org\/10.1002\/lt.20559","journal-title":"Liver Transpl"},{"issue":"3","key":"10834_CR94","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.amjsurg.2003.12.001","volume":"187","author":"V Smyrniotis","year":"2004","unstructured":"Smyrniotis V, Kostopanagiotou G, Theodoraki K, Tsantoulas D, Contis JC. The role of central venous pressure and type of vascular control in blood loss during major liver resections. Am J Surg 2004;187(3):398\u2013402. https:\/\/doi.org\/10.1016\/j.amjsurg.2003.12.001","journal-title":"Am J Surg"},{"key":"10834_CR95","doi-asserted-by":"publisher","DOI":"10.2373\/s0375-9393.19.13468-2","author":"G Biancofiore","year":"2019","unstructured":"Biancofiore G, Blasi A, De Boer MT, et al. Perioperative hemostatic management in the cirrhotic patient: a position paper on behalf of the Liver Intensive Care Group of Europe (LICAGE). Minerva Anestesiol. 2019. https:\/\/doi.org\/10.2373\/s0375-9393.19.13468-2","journal-title":"Minerva Anestesiol"},{"issue":"5","key":"10834_CR96","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/hep.0000000000000647","volume":"79","author":"DE Kaplan","year":"2024","unstructured":"Kaplan DE, Ripoll C, Thiele M, et al. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology 2024;79(5):1180\u20131211. https:\/\/doi.org\/10.1097\/hep.0000000000000647","journal-title":"Hepatology"},{"issue":"8","key":"10834_CR97","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1111\/liv.15621","volume":"43","author":"NM de Brito","year":"2023","unstructured":"de Brito NM, Knecht M, Wiest R, Bosch J, Berzigotti A. Predictors and management of post-banding ulcer bleeding in cirrhosis: a systematic review and meta-analysis. Liver Int 2023;43(8):1644\u20131653. https:\/\/doi.org\/10.1111\/liv.15621","journal-title":"Liver Int"},{"issue":"1","key":"10834_CR98","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5114\/ceh.2018.73668","volume":"4","author":"UA Sanglodkar","year":"2018","unstructured":"Sanglodkar UA, Jothimani D, Rela M. Hemospray for recurrent esophageal band ulcer bleeding. Clin Exp Hepatol 2018;4(1):46\u201348. https:\/\/doi.org\/10.5114\/ceh.2018.73668","journal-title":"Clin Exp Hepatol"},{"issue":"23","key":"10834_CR99","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.3390\/jcm12237355","volume":"12","author":"E Checcucci","year":"2023","unstructured":"Checcucci E, Piazzolla P, Marullo G, et al. Development of bleeding artificial intelligence detector (BLAIR) system for robotic radical prostatectomy. J Clin Med 2023;12(23):7355. https:\/\/doi.org\/10.3390\/jcm12237355","journal-title":"J Clin Med"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10834-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-025-10834-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10834-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:48:41Z","timestamp":1759949321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-025-10834-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10834"],"URL":"https:\/\/doi.org\/10.1007\/s12072-025-10834-2","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jessica P. E. Davis, Alberto Q. Farias, and Nicolas M. Intagliata have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}